Endocrine Disorders Associated with Obesity: Cushing's syndrome and Hypothyroidism
DOI:
https://doi.org/10.56294/hl2025594Keywords:
Polycystic ovary syndrome (PCOS), Hypothyroidism, Hypothalamic Obesity, Adrenocorticotrophic hormone (ACTH), Thyroid-stimulating hormone (TSH), Thyroid peroxides (TPO), CortisolAbstract
Obesity has been related to a wide range of endocrine disorders, from common ones including ovarian syndrome and hypothyroidism to unusual ones like Cushing's syndrome (CS), hypothyroidism, and hypothalamic abnormalities. Obesity can arise via a variety of endocrine disorders using several mechanisms. Multiple tissues accumulate hyaluronic acid, which causes greater fluid retention as a result of reduced thermogenesis and lower cardiac output, both of which are signs of hypothyroidism. The pathophysiology of obesity in polycystic ovarian syndrome is the unclear since it's possible that obesity both contributes to and harms polycystic ovarian syndrome. Net androgen excess seems to have a significant impact on the development of central adiposity. The interaction between thyroid and growth hormones, together with increased adipocyte differentiation and adiposity, is important in Cushing's illness. Additional peculiar situations are also examined in the research, such as hypothalamic obesity brought on by a concomitant hormonal deficiency and central hypothyroidism.
References
1. Paragliola RM, Corsello A, Papi G, Pontecorvi A, Corsello SM. Cushing’s syndrome effects on the thyroid. International journal of molecular sciences. 2021 Mar 19;22(6):3131.https://doi.org/10.3390/ijms22063131
2. Pivonello R, Bancos I, Feelders RA, Kargi AY, Kerr JM, Gordon MB, Mariash CN, Terzolo M, Ellison N, Moraitis AG. Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study. Frontiers in endocrinology. 2021 Jul 14;12:662865. https://doi.org/10.3389/fendo.2021.662865
3. Matejek N, Hoos J, Holterhus PM, Bettendorf M, Choukair D. Topical glucocorticoid application causing iatrogenic Cushing’s syndrome followed by secondary adrenal insufficiency in infants: two case reports. Journal of Medical Case Reports. 2022 Dec 8;16(1):455.https://doi.org/10.1186/s13256-022-03659-2
4. Jadoon N. Abstract# 1318176: Central Hypothyroidism Secondary to Cushing Syndrome From an ACTH-Producing Neuroendocrine Tumor. Endocrine Practice. 2022 Dec 1;28(12):S37.https://doi.org/10.1016/j.eprac.2022.10.074
5. Nieman LK. Molecular derangements and the diagnosis of ACTH-dependent Cushing’s syndrome. Endocrine Reviews. 2022 Oct 1;43(5):852-77.https://doi.org/10.1210/endrev/bnab046
6. Jurek, A., Krzesiński, P., Uziębło-Życzkowska, B., Witek, P., Zieliński, G., Wierzbowski, R., Kazimierczak, A., Banak, M. and Gielerak, G., 2024. Obesity-Related Hemodynamic Alterations in Patients with Cushing’s Disease. Journal of Clinical Medicine, 13(6), p.1658. https://doi.org/10.3390/jcm13061658
7. Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019 Mar 1;92:98-107.https://doi.org/10.1016/j.metabol.2018.10.011
8. Varlamov EV, Vila G, Fleseriu M. Perioperative management of a patient with Cushing disease. Journal of the Endocrine Society. 2022 Mar 1;6(3):bvac010. https://doi.org/10.1210/jendso/bvac010
9. Legaki AI, Moustakas II, Sikorska M, Papadopoulos G, Velliou RI, Chatzigeorgiou A. Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease. Current obesity reports. 2022 Sep;11(3):126-43.https://doi.org/10.1007/s13679-022-00473-1
10. Pardeshi SS, Khemani UN, Kamath RR, Kura MM, Jafferany M. Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study. Dermatologic Therapy. 2020 Nov;33(6):e14521.https://doi.org/10.1111/dth.14521
11. Crafa A, Calogero AE, Cannarella R, Mongioi’ LM, Condorelli RA, Greco EA, Aversa A, La Vignera S. The burden of hormonal disorders: a worldwide overview with a particular look in Italy. Frontiers in Endocrinology. 2021 Jun 16;12:694325.https://doi.org/10.3389/fendo.2021.694325
12. Webb SM, Valassi E. Consequences of Cushing’s syndrome: health versus personal costs. The Journal of Clinical Endocrinology & Metabolism. 2022 Sep 1;107(9):e3959-60. https://doi.org/10.1210/clinem/dgac269
13. Pasquali R, Casanueva F, Haluzik M, Van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity. European journal of endocrinology. 2020 Jan;182(1):G1-32. https://doi.org/10.1530/EJE-19-0893
14. Nayak PK, Mitra S, Sahoo J, Mahapatra E, Agrawal S, Lone Z. Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients. Journal of family medicine and primary care. 2020 Jan 1;9(1):147-50.https://doi.org/10.10.4103/jfmpc.jfmpc_654_19
15. Ali R, Fernandez-Lopez K, Maria Belalcazar L. PMON98 High-dose dexamethasone suppression test in ACTH-dependent Cushing's syndrome: Lessons learned on the lack of cortisol suppression. Journal of the Endocrine Society. 2022 Nov 1;6(Supplement_2):A572-3.https://doi.org/10.1210/jendso/bvac150.1187
16. Lee HJ, Jo HN, Noh HK, Kim SH, Joo JK. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?. Ginekologia Polska. 2023;94(3):203-10. 10.5603/GP.a2021.0239
17. Gambineri A, Cecchetti C, Altieri P, Ribichini D, Preiato VL, Fanelli F, Pagotto U. Secondary PCOS: Well-defined causes, leading to the PCOS phenotype. InPolycystic Ovary Syndrome 2022 Jan 1 (pp. 15-22). Elsevier.https://doi.org/10.1016/B978-0-12-823045-9.00008-0
18. de Silva NL, Somasundaram N, Constantine R, Kularatna H. Apoplexy of Crooke cell tumour leading to the diagnosis of severe Cushing disease; a case report. BMC Endocrine Disorders. 2021 May 1;21(1):93.https://doi.org/10.1186/s12902-021-00761-2
19. Gao C. Clinical features of endocrine diseases complicated with rhabdomyolysis. Journal of Xi'an Jiaotong University (Medical Sciences). 2020:919-22.
20. Fleseriu, M., Rosario Pivonello, M.D., AtanaskaElenkova, M.D., Salvatori, R., Richard Feelders, M.D., Geer, E., Greenman, Y., Przemyslaw Witek, M.D. and Biller, B., 2019. LEVOKETOCONAZOLE IN THE TREATMENT OF ENDOGENOUS CUSHING'S SYNDROME: IMPROVEMENTS IN CLINICAL SIGNS AND SYMPTOMS, PATIENT-REPORTED OUTCOMES, AND ASSOCIATED BIOCHEMICAL MARKERS IN THE PHASE 3 SONICS STUDY. Endocrine Practice, 25, pp.245-246.
21. Maldar A, Kulkarni A, Chauhan P, Misra B, Shah N, Chadha M. Single-center experience with Bilateral Inferior Petrosal Sinus Sampling (BIPSS) in adrenocorticotropin-dependent Cushing's syndrome. Indian Journal of Endocrinology & Metabolism. 2022 Dec 2;26.https://doi.org/10.4103/2230-8210.363665
22. Vielkind M, Tommerdahl K, Hawkins S, Mohon RT. Multiple subspecialists involved in late diagnosis of rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation syndrome. InC47. CASE REPORTS: PEDIATRIC CYSTIC FIBROSIS, LUNG INFECTION, AND SLEEP DISORDERED BREATHING 2019 May (pp. A4981-A4981). American Thoracic Society.https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A4981
23. Lesia Z, Larysa Z. PRETERM LABOR: THE INFLUENCE OF ENDOCRINE DISORDERS. InThe 6th International scientific and practical conference “Multidisciplinary scientific notes. Theory, history and practice”(November 01–04, 2022) Edmonton, Canada. International Science Group. 2022. 712 p. 2022 Nov 1 (p. 384).
24. Ahmed SF, Bapir R, Fattah FH, Mahmood AG, Salih RQ, Salih AM, Tahir SH, Kakamad FH. Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review. International Journal of Surgery Case Reports. 2022 May 1;94:107038.https://doi.org/10.1016/j.ijscr.2022.107038
25. Parksook WW, Laichuthai N, Sunthornyothin S. Clinical Characteristics and Treatment Outcomes in Endogenous Cushing’s Syndrome: A 15‐Year Experience from Thailand. Case Reports in Endocrinology. 2020;2020(1):2946868.https://doi.org/10.1155/2020/2946868
26. Bostan H, Duger H, Akhanli P, Calapkulu M, Turkmenoglu TT, Erdol AK, Duru SA, Sencar ME, Kizilgul M, Ucan B, Ozbek M. Cushing’s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review. Hormones. 2022 Mar:1-8.https://doi.org/10.1007/s42000-021-00316-z
27. Chong HP, Alazzani H, Boelaert K. Endocrine disorders in pregnancy. Obstetrics, Gynaecology& Reproductive Medicine. 2019 Nov 1;29(11):301-5.https://doi.org/10.1016/j.ogrm.2019.08.005
28. Paharia N. Evaluation of Dry Eyes in Hypothyroid patients in comparison to Euthyroid subjects. Indian Journal of Endocrinology & Metabolism. 2022 Dec 2;26.https://doi.org/10.4103/2230-8210.363703
29. Wijewickrama PS, Ratnasamy V, Somasundaram NP, Sumanatilleke M, Ambawatte SB. A challenging case of Cushing’s disease complicated with multiple thrombotic phenomena following trans-sphenoidal surgery; a case report. BMC Endocrine Disorders. 2021 Dec;21:1-7.https://doi.org/10.1186/s12902-021-00701-0
30. Matarneh AS, Hamad AO, Hamad MK, Elouzi EB, Mahmood NS, Al‐Sawalmeh K, Al‐Bozom I, Hussein MS, Yassin MA. A rare initial presentation of a thymic neuroendocrine tumor as Cushing's syndrome. Clinical Case Reports. 2021 Jul;9(7):e04435.https://doi.org/10.1002/ccr3.4435
31. Gorlanov IA, Leina LM, Skorodok YL, Milyavskaya IR. Cutaneous manifestations of endocrine diseases in children. Pediatrician (St. Petersburg). 2021 Aug 11;12(2):53-64.https://doi.org/10.17816/PED12253-64
32. Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, Stewart PM. The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. The Journal of Clinical Endocrinology & Metabolism. 2022 Aug 1;107(8):2377-88.https://doi.org/10.1210/clinem/dgac265.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rahul Thakur , Navya Raj MP, Dheeravath Raju , Rakhi Mishra , Abhinav Mishra , Swayamsidha Mangaraj (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
